Product Name: Human TGM2 / Transglutaminase 2 Antibody (Zampilimab, Research Use)
Catalog Number: NBR-0888
Target Name: TGM2 / Transglutaminase 2
Trade Name: Zampilimab
Antibody Drug Description: Zampilimab is an anti-transglutaminase 2 monoclonal antibody intended for the treatment of fibrosis such as Idiopathic Pulmonary Fibrosis (IDF) and Chronic Kidney Disease (CAI). Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: TGM2
Synonyms: TGC
Target Description: Calcium-dependent acyltransferase that catalyzes the formation of covalent bonds between peptide-bound glutamine and various primary amines, such as gamma-amino group of peptide-bound lysine, or mono- and polyamines, thereby producing cross-linked or aminated proteins, respectively.
Ensembl:  ENSG00000198959
Uniprot: P21980